The STEPP Study: Sensors To Evaluate Physical Performance
NCT03952767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2022-10-25
Summary
This study assesses the association between digital functional measures of physical and patient-reported standard onocological assessments, like Karnofsky Performance Score (KPS).
Conditions
Interventions
- OTHER
-
Digital Physical Measures and Survey Assessments
Data from at home and in clinic visits will assess physical function and survey data will be collected
Sponsors & Collaborators
- collaborator INDUSTRY
-
UNC Lineberger Comprehensive Cancer Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-24
- Primary Completion
- 2021-08-30
- Completion
- 2022-08-30
Countries
- United States
Study Locations
More Related Trials
-
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
NCT02761460 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Darbepoetin Alfa
NCT00540696 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation of Timing of Pegfilgrastim Administration and PIBP.
NCT05841186 ·Status: RECRUITING ·Phase: NA
-
An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)
NCT03433560 ·Status: COMPLETED
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)
NCT00115414 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
NCT01813721 ·Status: COMPLETED
-
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
NCT00277160 ·Status: COMPLETED ·Phase: PHASE4
-
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia
NCT03294577 ·Status: UNKNOWN ·Phase: PHASE3
-
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
NCT06616571 ·Status: RECRUITING ·Phase: PHASE4
-
Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
NCT00120679 ·Status: COMPLETED ·Phase: PHASE2
-
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy
NCT00115206 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis
NCT03701841 ·Status: UNKNOWN
-
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
NCT00335478 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
NCT01450241 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
NCT02866851 ·Status: TERMINATED ·Phase: NA
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients
NCT01238562 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
NCT00117442 ·Status: COMPLETED ·Phase: PHASE2
-
Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy
NCT04477616 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy
NCT03776032 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
NCT01484015 ·Status: COMPLETED ·Phase: PHASE1
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients
NCT01637493 ·Status: UNKNOWN ·Phase: PHASE1